| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. (OLMA) has 17 insiders with recent SEC Form 4 filings, including 5 buys and 14 sells. OLMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 737.8K | $11.10M | - | |
| CEO | 275.0K | $4.14M | - | |
| Other | 250.0K | $3.76M | - | |
| Other | 139.7K | $2.10M | - | |
| Other | 106.3K | $1.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | Harmon Cyrus72 | Director | Sell | 25,000 | $10.30 | $257,450.00 | -1.0% | -18.9% | -69.8% | |
| Jun 4, 2024 | Graham G. Walmsley48 | Director | Sell | 1,175,000 | $14.85 | $17,448,750.00 | -45.5% | -18.9% | -69.8% | |
| May 6, 2024 | Harmon Cyrus72 | Director | Sell | 5,000 | $10.92 | $54,600.00 | -0.6% | +27.2% | -57.8% | |
| Apr 30, 2024 | Harmon Cyrus72 | Director | Sell | 15,000 | $9.51 | $142,650.00 | -1.8% | +49.4% | -49.3% | |
| Mar 28, 2024 | Harmon Cyrus72 | Director | Sell | 20,000 | $10.97 | $219,400.00 | -2.4% | -2.3% | -63.7% | |
| Feb 29, 2024 | Harmon Cyrus72 | Director | Sell | 25,000 | $12.41 | $310,309.00 | -1.5% | -22.2% | -64.8% | |
| Feb 1, 2024 | Harmon Cyrus72 | Director | Sell | 30,000 | $12.79 | $383,550.00 | -1.7% | -31.8% | -59.9% | |
| Dec 29, 2023 | Harmon Cyrus72 | Director | Sell | 25,000 | $13.38 | $334,500.00 | -1.4% | -19.3% | -56.2% | |
| Dec 6, 2023 | Paradigm Biocapital Advisors LP | 10% Owner | Buy | 100,000 | $11.60 | $1,160,000.00 | +1.5% | +18.0% | -12.3% | |
| Dec 5, 2023 | Graham G. Walmsley48 | Director | Buy | 640,000 | $10.74 | $6,871,279.47 | +10.2% | +12.8% | -21.8% |